巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Phibro Animal Health Corp

    PAHC
    19.490
    0.520
    2.74%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Phibro Animal Health Corp - 延遲價格・最後更新於 27/05 12:14
    最高位
    19.610
    最低位
    19.050
    開市價
    --
    前收市價
    18.970
    成交量(千)
    1.24
    成交額(百萬)
    0.20
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    789.42
    市盈率
    13.440
    息率
    2.53%
    差價
    --
    52週高低
    31.000 - 17.280
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Phibro Animal Health Corp
    證券代碼
    PAHC.US
    所屬板塊
    Drug Manufacturers - Specialty & Generic
    公司業務
    Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the US and other international countries.
    發行量
    40503608
    公司總部
    300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East
    公司網址
    https://www.pahc.com
    公司電郵
    investor.relations@pahc.com
    公司電話
    +1 201 329-7300
    暫無內容

    關於

    Phibro Animal Health Corp(PAHC.US)所屬的行業板塊為Drug Manufacturers - Specialty & Generic。
    Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the US and other international countries.
    截至27/05 12:14:59,Phibro Animal Health Corp的股價升2.74,市值789.42百萬。Phibro Animal Health Corp的市盈率及息率分別為13.440及2.53%。
    詳細公司背景可參考: https://www.pahc.com